# Celularity Inc. (CELU) FY2026 Q1 Balance Sheet

- Company: Celularity Inc. (CELU)
- Period: As of 2026-03-31
- Filing: Q1 FY2026 10-Q, filed 2026-09-29, accession number 0001493152-26-044892
- Page: https://plicit.ai/financials/celu/fy2026-q1-balance-sheet
- Chart image: https://plicit.ai/charts/celu-fy2026-q1-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-03-31. The chart shows assets, liabilities and equity at that date.

- **Assets**: 99,480,000 US dollars
- **Current assets**: 6,301,000 US dollars
- **Non-current assets**: 93,179,000 US dollars
- **Liabilities**: 134,741,000 US dollars
- **Current liabilities**: 70,583,000 US dollars
- **Non-current liabilities**: 64,158,000 US dollars
- **Equity**: negative 35,261,000 US dollars
- **Accounts receivable, net of allowance of $7,847 and $7,647 as of March 31, 2026 and December 31, 2025, respectively**: 4,781,000 US dollars
- **Prepaid expenses and other current assets**: 675,000 US dollars
- **Inventory**: 477,000 US dollars
- **Cash and cash equivalents**: 368,000 US dollars
- **Property and equipment, net**: 54,568,000 US dollars
- **Right-of-use assets - operating**: 10,701,000 US dollars
- **Restricted cash**: 10,109,000 US dollars
- **Intangible assets, net**: 7,388,000 US dollars
- **Goodwill**: 7,347,000 US dollars
- **Inventory, net of current portion**: 2,825,000 US dollars
- **Other long-term assets**: 241,000 US dollars
- **Accrued expenses and other current liabilities**: 30,903,000 US dollars
- **Accounts payable**: 25,100,000 US dollars
- **Short-term debt - Related Party**: 4,606,000 US dollars
- **Deferred revenue**: 4,025,000 US dollars
- **Short-term license obligation**: 3,170,000 US dollars
- **Short-term debt - Nonrelated Party**: 2,687,000 US dollars
- **Derivative liability**: 92,000 US dollars
- **Long-term license obligation**: 30,642,000 US dollars
- **Noncurrent lease liabilities - operating**: 26,975,000 US dollars
- **Deferred revenue, net of current portion**: 3,221,000 US dollars
- **Warrant liabilities**: 1,632,000 US dollars
- **Noncurrent acquisition - related contingent consideration**: 1,413,000 US dollars
- **Other liabilities**: 263,000 US dollars
- **Deferred income tax liabilities**: 12,000 US dollars
- **Additional paid-in capital**: 955,345,000 US dollars
- **Common Stock, $0.0001 par value, 730,000,000 shares authorized; 29,179,751 and 28,837,787 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively**: 3,000 US dollars
- **Accumulated deficit**: negative 990,609,000 US dollars

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.